AVIS : Entraves à la circulation sur la rue Saint-Denis les 2, 3 et 4 mars. Merci de prévoir vos déplacements.

ALS research: grants for Christine Vande Velde and Alex Parker

- 1 min
Christine Vande Velde et Alex Parker

Researchers Christine Vande Velde and Alex Parker

Christine Vande Velde and Alex Parker, two researchers at the CHUM Research Centre (CRCHUM), were awarded Discovery Grants to advance research on amyotrophic lateral sclerosis (ALS).

The ALS Society of Canada and the Brain Canada Foundation, with the support of the Fonds Dr. Jean-Pierre Canuel—SLA Québec, have selected their two research projects to advance scientific knowledge.

This program supports projects that are focused on identifying causes of ALS, treatments for ALS or related neurological diseases, and avenues to maximize function, minimize disability, and optimize quality of life for persons and families living with ALS.

The two projects of the CRCHUM scientists

What role does its sister protein play when restoring G3BP1 levels as a potential ALS treatment strategy?
Christine Vande Velde, in collaboration with Dr. Marlene Oeffinger at the Institut de recherches cliniques de Montréal (IRCM), was awarded $125,000.

Could protecting the axon represent a promising treatment strategy for ALS?
In partnership with the Fonds Dr. Jean-Pierre Canuel—SLA Québec and the Brain Canada Foundation, Alex Parker has received $300,000. He will collaborate with Gary Armstrong of McGill University.

A total of nine Discovery Grants, valued at over $1.4 million, were awarded to multidisciplinary research teams from across Canada.

Learn more about all funded projects: ALS Canada.